Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 3
2008 2
2009 1
2010 2
2011 1
2012 1
2013 2
2014 3
2015 2
2016 1
2017 2
2018 4
2019 2
2021 4
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
New hormone receptor-positive breast cancer mouse cell line mimicking the immune microenvironment of anti-PD-1 resistant mammary carcinoma.
Perez-Lanzon M, Carbonnier V, Cordier P, De Palma FDE, Petrazzuolo A, Klein C, Arbaretaz F, Mangane K, Stoll G, Martins I, Fohrer Ting H, Paillet J, Mouillet-Richard S, Le Corre D, Xiao W, Sroussi M, Desdouets C, Laurent-Puig P, Pol J, Lopez-Otin C, Maiuri MC, Kroemer G. Perez-Lanzon M, et al. Among authors: le corre d. J Immunother Cancer. 2023 Jun;11(6):e007117. doi: 10.1136/jitc-2023-007117. J Immunother Cancer. 2023. PMID: 37344100 Free PMC article.
ERBB3-Activating Mutations in Small Bowel Adenocarcinomas.
Cabel L, Aparicio T, Bieche I, Svrcek M, Zaanan A, Afchain P, Di Fiore F, Gornet JM, Le Corre D, Vacher S, Callens C, Bernard V, Laurent-Puig P, Bidard FC. Cabel L, et al. Among authors: le corre d. JCO Precis Oncol. 2018 Nov;2:1-9. doi: 10.1200/PO.17.00243. JCO Precis Oncol. 2018. PMID: 35135114
BRCA1 and RAD51C promotor methylation in human resectable pancreatic adenocarcinoma.
Abdallah R, Zhao S, Garinet S, Hormigos K, Le Corre D, Cros J, Perez Toralla K, Bats AS, Augustin J, Bachet JB, Taly V, Blons H, Taieb J, Laurent-Puig P. Abdallah R, et al. Among authors: le corre d. Clin Res Hepatol Gastroenterol. 2022 May;46(5):101880. doi: 10.1016/j.clinre.2022.101880. Epub 2022 Feb 11. Clin Res Hepatol Gastroenterol. 2022. PMID: 35151910
Development and validation of a RNAseq signature for prognostic stratification in endometrial cancer.
Beinse G, Le Frere Belda MA, Just PA, Bekmezian N, Koual M, Garinet S, Leroy K, Letourneur F, Lusson A, Mulot C, Le Corre D, Metairie M, Delanoy N, Blons H, Gervais C, Durdux C, Chapron C, Goldwasser F, Terris B, Badoual C, Taly V, Laurent-Puig P, Borghese B, Bats AS, Alexandre J. Beinse G, et al. Among authors: le corre d. Gynecol Oncol. 2022 Mar;164(3):596-606. doi: 10.1016/j.ygyno.2022.01.005. Epub 2022 Jan 13. Gynecol Oncol. 2022. PMID: 35033379
Prognostic value of the PrPC-ILK-IDO1 axis in the mesenchymal colorectal cancer subtype.
Ghazi A, Le Corre D, Pilati C, Taieb J, Aparicio T, Didelot A, Dedhar S, Mulot C, Le Malicot K, Djouadi F, de Reynies A, Launay JM, Laurent-Puig P, Mouillet-Richard S. Ghazi A, et al. Among authors: le corre d. Oncoimmunology. 2021 Jun 28;10(1):1940674. doi: 10.1080/2162402X.2021.1940674. eCollection 2021. Oncoimmunology. 2021. PMID: 34249475 Free PMC article.
A proof of concept for targeting the PrPC - Amyloid β peptide interaction in basal prostate cancer and mesenchymal colon cancer.
Mouillet-Richard S, Martin-Lannerée S, Le Corre D, Hirsch TZ, Ghazi A, Sroussi M, Pilati C, de Reyniès A, Djouadi F, Vodovar N, Launay JM, Laurent-Puig P. Mouillet-Richard S, et al. Among authors: le corre d. Oncogene. 2022 Sep;41(38):4397-4404. doi: 10.1038/s41388-022-02430-7. Epub 2022 Aug 12. Oncogene. 2022. PMID: 35962130 Free PMC article.
Circulating tumor DNA is a prognostic marker of tumor recurrence in stage II and III colorectal cancer: multicentric, prospective cohort study (ALGECOLS).
Benhaim L, Bouché O, Normand C, Didelot A, Mulot C, Le Corre D, Garrigou S, Djadi-Prat J, Wang-Renault SF, Perez-Toralla K, Pekin D, Poulet G, Landi B, Taieb J, Selvy M, Emile JF, Lecomte T, Blons H, Chatellier G, Link DR, Taly V, Laurent-Puig P. Benhaim L, et al. Among authors: le corre d. Eur J Cancer. 2021 Dec;159:24-33. doi: 10.1016/j.ejca.2021.09.004. Epub 2021 Oct 30. Eur J Cancer. 2021. PMID: 34731746
Prognostic Value of Methylator Phenotype in Stage III Colon Cancer Treated with Oxaliplatin-based Adjuvant Chemotherapy.
Gallois C, Taieb J, Le Corre D, Le Malicot K, Tabernero J, Mulot C, Seitz JF, Aparicio T, Folprecht G, Lepage C, Mini E, Van Laethem JL, Emile JF, Laurent-Puig P; PETACC8 investigators. Gallois C, et al. Among authors: le corre d. Clin Cancer Res. 2018 Oct 1;24(19):4745-4753. doi: 10.1158/1078-0432.CCR-18-0866. Epub 2018 Jun 19. Clin Cancer Res. 2018. PMID: 29921730 Clinical Trial.
35 results